EVA MARÍA
CIRUELOS GIL
Profesora asociada de Ciencias de la Salud
Universidad Autónoma de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (5)
2020
2019
-
A Pilot, Phase II, Randomized, Open-Label Clinical Trial Comparing the Neurotoxicity of Three Dose Regimens of Nab-Paclitaxel to That of Solvent-Based Paclitaxel as the First-Line Treatment for Patients with Human Epidermal Growth Factor Receptor Type 2-Negative Metastatic Breast Cancer
Oncologist, Vol. 24, Núm. 11, pp. e1024-e1033
-
Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: An estimation of life years and disease-free life years gained since its approval
Oncotarget, Vol. 10, Núm. 42, pp. 4321-4332
-
Ribociclib-related stevens–johnson syndrome: Oncologic awareness, case report, and literature review
Journal of Breast Cancer, Vol. 22, Núm. 4, pp. 661-666
-
SEOM clinical guidelines in early stage breast cancer (2018)
Clinical and Translational Oncology, Vol. 21, Núm. 1, pp. 18-30